IN8bio Inc INAB Q1 2026 Earnings EPS Surprise of 63 Highlights Cost Discipline in PreRevenue Biotech IMMR Q3 2025 Earnings EPS Beats Estimates by 1878 Stock Rises NVT Q1 2026 Earnings EPS Beats Estimates by Nearly 15 Shares Rise GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development KG Q3 2024 Earnings A Loss of 016 per Share as Stock Declines FBLG Q1 2026 Earnings PreRevenue Biotech Posts Slight EPS Miss No Revenue Reported